BiotechTube
Home/Pipeline/Lipaglyn

Lipaglyn

Type 2 Diabetes

ApprovedCommercial

Key Facts

Indication
Type 2 Diabetes
Phase
Approved
Status
Commercial
Company
Zydus Lifesciences

About Zydus Lifesciences

Zydus Lifesciences Limited, formerly Cadila Healthcare, is a leading Indian multinational pharmaceutical company founded in 1952. The company operates across the entire pharmaceutical value chain with a strong presence in generic drugs, biosimilars, and consumer healthcare products. With manufacturing facilities in India and the US, Zydus serves markets globally including the United States, Europe, and emerging markets, maintaining a robust pipeline of over 300 molecules under development.

View full company profile

Therapeutic Areas

DiabetesCardiovascularRespiratoryOncologyGastroenterologyPain ManagementDermatologyVaccines

Other Type 2 Diabetes Drugs

DrugCompanyPhase
Tirzepatide (Mounjaro)Eli LillyApproved
OrforglipronEli LillyPhase 3
Trulicity (dulaglutide)Eli LillyApproved
ForxigaAstraZenecaApproved
siRNA GalXC-GYS2Novo NordiskPhase 1
Amylin/semaglutide combinationNovo NordiskPhase 3
LBS-009Belite BioPreclinical
Jentadueto (Linagliptin/Metformin)YuhanApproved
Nesina (Alogliptin)YuhanApproved
Metformin & CombinationsIpca LaboratoriesCommercial
GSBR-1290Structure TherapeuticsPhase 2
MetforminGranules IndiaApproved/Commercial